Table 1 Baseline demographic and clinical characteristics of patients with T2D in Ethiopia, 2018
Category | Subcategory | Statin use (N = 323) | Total (%) | P value | |
|---|---|---|---|---|---|
Not received | Received | ||||
Sex | Male | 64 (44.8) | 93 (51.7) | 157 (48.6) | 0.57 |
Female | 79 (55.2) | 87 (48.3) | 166 (51.4) | ||
Age group | 40–64 | 86 (60.1) | 102 (56.7) | 188 (58.2) | 0.33 |
65–75 | 57 (39.9) | 78 (43.3) | 135 (41.8) | ||
BMI (kg/m2) | Mean (± SD) | 26 ± 3 | 26 ± 3 | 28.23 ± 2.3 | 0.161 |
Duration of diabetes | Mean (± SD) | 11.03 ± 6 | 13.12 ± 7 | 11.9 ± 6.9 | 0.051 |
Presence of comorbidities | Yes | 77 (53.4) | 175 (97.2) | 250 (77.9) | 0.115 |
No | 66 (46.2) | 5 (2.8) | 71 (22.1) | ||
Types of co morbidities | Hypertension | 60 (72.3) | 112 (63.6) | 172 (66.4) | 0.169 |
Dyslipidemia | 7 (9) | 148 (84.6) | 155 (61.3) | 0.000 | |
IHD | 3 (3.8) | 30 (17.0) | 33 (13.0) | 0.004 | |
Othersa | 13 (16.5) | 32 (18.3) | 45 (17.7) | 0.724 | |
Presence of complications | Yes | 56 (35.5) | 58 (32.2) | 108 (33.6) | 0.061 |
No | 91 (64.5) | 122 (67.8) | 213 (66.4) | ||
Types of complications | Neuropathy | 42 (75.0) | 40 (61.5) | 82 (67.8) | 0.114 |
Nephropathy | 7 (12.3) | 9 (13.6) | 16 (13) | 0.824 | |
Retinopathy | 8 (14) | 17 (25.4) | 25 (20.2) | 0.117 | |
FBG, mg/dL | Mean (± SD) | 171.9 ± 49.7 | 178.1 ± 48.1 | 174.10 ± 48.9 | < 0.001 |
> 130 mg/dL | 41 (28.6) | 59 (32.8) | 241 (74.6%) | 0.003 | |
LDL, mg/dL | Mean (± SD) | 109.1 ± 33 | 119 ± 50 | 115.7 ± 35.6 | 0.081 |
≥ 100 | 181 (74.2) | 41 (36.3) | 222 (62.2) | 0.058 | |
HDL, mg/dL | Mean (± SD) | 46 ± 16 | 44 ± 16 | 41.8 ± 10.2 | 0.624 |
≤ 40, male, ≤ 50, female | 121 (49.6) | 52 (46.0) | 173 (48.5) | 0.712 | |
Triglycerides, mg/dL | Mean (± SD) | 159 ± 62 | 94 ± 118 | 158.2 ± 121.2 | 0.154 |
≥ 150 | 113 (46.3) | 33 (29.2) | 146 (40.9) | 0.081 | |
Total cholesterol, mg/dL | Mean (± SD) | 181 ± 34 | 193 ± 54 | 165.54 ± 38.3 | 0.067 |
≥ 200 mg/dL | 68 (27.9) | 29 (25.7) | 97 (27.2) | 0.121 | |
Overall cholesterol level | On target | 21 (14.7) | 109 (60.6) | 130 (40.2) | |
Not on target | 122 (85.3) | 71 (39.4) | 193 (59.8) | 0.171 | |
eGFR, mL/min/1.73 m2 | ≤45 | 31 (12.7) | 13 (11.50) | 44 (12.3) | 0.221 |
BP (mmHg), mean (± SD) | Systolic BP | 144.18 ± 47.24 | 139 ± 20 | 151.17 ± 62.07 | 0.415 |
Diastolic BP | 84 ± 14 | 81 ± 9 | 85.11 ± 0.08 | 0.281 | |
Systolic/diastolic | >140/90 | 98 (40.2) | 19 (16.8) | 117 (32.8) | 0.078 |
Risk factors | Low (T2D alone) | 141 (98.6) | 93 (51.7) | 234 (72.5) | 0.031 |
Medium (2–3) | 2 (1.4) | 61 (33.9) | 63 (19.5) | 0.009 | |
High (≥4) | 0 (0.0) | 26 (14.4) | 26 (8.0) | 0.002 | |